These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15222582)

  • 21. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis.
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    J Am Acad Dermatol; 1999 Dec; 41(6):987-90. PubMed ID: 10570385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of compensatory hyperhidrosis with botulinum toxin type A.
    Belin EE; Polo J
    Cutis; 2003 Jan; 71(1):68-70. PubMed ID: 12553633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS; Halem ML
    Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
    Sampaio C; Ferreira JJ; Simões F; Rosas MJ; Magalhães M; Correia AP; Bastos-Lima A; Martins R; Castro-Caldas A
    Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A; Carruthers J
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Information from your family doctor. Cosmetic botulinum toxin injection.
    Am Fam Physician; 2014 Aug; 90(3):Online. PubMed ID: 25077726
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.
    Goodman G
    Dermatol Surg; 2003 May; 29(5):533-8; discussion 538. PubMed ID: 12752524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of botulinum toxins: past, present, and future.
    Cartee TV; Monheit GD
    Clin Plast Surg; 2011 Jul; 38(3):409-26, vi. PubMed ID: 21824539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial comment on the use of botulinum toxin.
    Moore AP
    Eur J Neurol; 2012 Mar; 19(3):357-8. PubMed ID: 22040329
    [No Abstract]   [Full Text] [Related]  

  • 34. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are botulinum toxin type A preparations really the same medication? A comparison of three botulinum toxin A for variations in labelled neurological indications].
    Sławek J; Car H; Bonikowski M; Bogucki A; Koziorowski D; Potulska-Chromik A; Rudzińska M
    Neurol Neurochir Pol; 2010; 44(1):43-64. PubMed ID: 20358485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating childhood hyperhidrosis with botulinum toxin type A.
    Bhakta BB; Roussounnis SH
    Arch Dis Child; 2002 Jan; 86(1):68. PubMed ID: 11806899
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
    Glogau RG
    Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.